Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

IF 3.7 2区 医学 Q1 PSYCHOLOGY, CLINICAL
Allison R. David , Carlos R. Sian , Christina M. Gebel , Benjamin P. Linas , Jeffrey H. Samet , Linda S. Sprague Martinez , Jordana Muroff , Judith A. Bernstein , Sabrina A. Assoumou
{"title":"Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study","authors":"Allison R. David ,&nbsp;Carlos R. Sian ,&nbsp;Christina M. Gebel ,&nbsp;Benjamin P. Linas ,&nbsp;Jeffrey H. Samet ,&nbsp;Linda S. Sprague Martinez ,&nbsp;Jordana Muroff ,&nbsp;Judith A. Bernstein ,&nbsp;Sabrina A. Assoumou","doi":"10.1016/j.jsat.2022.108870","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p><span>Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from </span>drug overdose<span> in the United States in recent years. Patient perceived barriers to evidence-based treatment after completion of short-term inpatient medically managed withdrawal programs (detox) have not been well studied. The purpose of the current study is to elicit patients' perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions.</span></p></div><div><h3>Methods</h3><p>We conducted semi-structured interviews (<em>N</em> = 24) at a detox center (2018–2019) to explore patients' perspectives on obstacles to treatment. The study managed the data in NVivo and we used content analysis to identify themes.</p></div><div><h3>Results</h3><p>Patients' characteristics included the following: 54 % male; mean age 37 years; self-identified as White 67 %, Black 13 %, Latinx 8 %, Native Hawaiian/Pacific Islander 4 %, and other 8 %; heroin use in the past 3 months 67 %; and ever injecting drugs<span> 71 %. Patients identified the following barriers: 1) lack of continuity of care; 2) limited number of detox and residential treatment program beds; 3) unstable housing; and 4) lack of options when choosing a treatment pathway. Solutions proposed by participants included: 1) increase low-barrier access to community MOUD; 2) add case managers at the detox center to establish continuity of care after discharge; 3) increase assistance with housing; and 4) encourage patient participation in treatment decisions.</span></p></div><div><h3>Conclusions</h3><p>Patients identified lack of continuity of care, especially care coordination, as a major barrier to substance use treatment. Increasing treatment utilization, including MOUD, necessitates a multimodal approach to continuity of care, low-barrier access to MOUD, and support to address unstable housing. Patients want care that incorporates options and respect for.</p><p>individualized preferences and needs.</p></div>","PeriodicalId":17148,"journal":{"name":"Journal of Substance Abuse Treatment","volume":"142 ","pages":"Article 108870"},"PeriodicalIF":3.7000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Substance Abuse Treatment","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0740547222001520","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction

Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from drug overdose in the United States in recent years. Patient perceived barriers to evidence-based treatment after completion of short-term inpatient medically managed withdrawal programs (detox) have not been well studied. The purpose of the current study is to elicit patients' perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions.

Methods

We conducted semi-structured interviews (N = 24) at a detox center (2018–2019) to explore patients' perspectives on obstacles to treatment. The study managed the data in NVivo and we used content analysis to identify themes.

Results

Patients' characteristics included the following: 54 % male; mean age 37 years; self-identified as White 67 %, Black 13 %, Latinx 8 %, Native Hawaiian/Pacific Islander 4 %, and other 8 %; heroin use in the past 3 months 67 %; and ever injecting drugs 71 %. Patients identified the following barriers: 1) lack of continuity of care; 2) limited number of detox and residential treatment program beds; 3) unstable housing; and 4) lack of options when choosing a treatment pathway. Solutions proposed by participants included: 1) increase low-barrier access to community MOUD; 2) add case managers at the detox center to establish continuity of care after discharge; 3) increase assistance with housing; and 4) encourage patient participation in treatment decisions.

Conclusions

Patients identified lack of continuity of care, especially care coordination, as a major barrier to substance use treatment. Increasing treatment utilization, including MOUD, necessitates a multimodal approach to continuity of care, low-barrier access to MOUD, and support to address unstable housing. Patients want care that incorporates options and respect for.

individualized preferences and needs.

住院患者管理性停药(Detox)后获得药物使用治疗的障碍:一项定性研究。
引言:尽管近年来美国因药物过量导致的死亡人数很高,但药物使用障碍,特别是阿片类药物使用障碍(OUD)的循证治疗的获得和接受是有限的。在完成短期住院医学管理的戒断计划(排毒)后,患者对循证治疗的感知障碍尚未得到很好的研究。当前研究的目的是引出患者对过渡到治疗的挑战的看法,包括排毒后的OUD药物和潜在的解决方案。方法:我们在戒毒中心(2018-2019)进行了半结构化访谈(N=24),以探讨患者对治疗障碍的看法。该研究对NVivo中的数据进行了管理,我们使用内容分析来确定主题。结果:患者特征包括:54%为男性;平均年龄37岁;自称白人67%,黑人13%,拉丁裔8%,夏威夷原住民/太平洋岛民4%,其他8%;过去3个月海洛因使用率67%;曾注射毒品者占71%。患者发现了以下障碍:1)缺乏连续性的护理;2) 戒毒和住院治疗计划床位数量有限;3) 住房不稳定;以及4)在选择治疗途径时缺乏选择。与会者提出的解决方案包括:1)增加社区谅解备忘录的低障碍准入;2) 在排毒中心增加病例管理人员,以建立出院后护理的连续性;3) 增加住房援助;以及4)鼓励患者参与治疗决策。结论:患者认为缺乏连续性的护理,尤其是护理协调,是药物使用治疗的主要障碍。增加包括MOUD在内的治疗利用率,需要采取多模式的方法来实现护理的连续性,低障碍地获得MOUD,并支持解决不稳定的住房问题。患者需要包含选择和尊重的护理。个性化的偏好和需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.60
自引率
10.30%
发文量
220
期刊介绍: The Journal of Substance Abuse Treatment (JSAT) features original reviews, training and educational articles, special commentary, and especially research articles that are meaningful to the treatment of alcohol, heroin, marijuana, and other drugs of dependence. JSAT is directed toward treatment practitioners from all disciplines (medicine, nursing, social work, psychology, and counseling) in both private and public sectors, including those involved in schools, health centers, community agencies, correctional facilities, and individual practices. The editors emphasize that JSAT articles should address techniques and treatment approaches that can be used directly by contemporary practitioners.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信